Home › Research › Topics › tau-biomarkers
tau-biomarkers
5 studies tagged tau-biomarkers, dated 2020-07-02 to 2025-08-06. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles 2025-08-06
- Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population 2025-06-23
- Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease 2024-12-06
Studies
5 studies carry this tag.
Date range
2020 to 2025
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Cells 1
- European journal of nuclear medicine and molecular imaging 1
- Nature aging 1
- NeuroImage. Clinical 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Plasma pTau217 is effective for predicting A/T biomarker profile and cognitive decline, though further study is needed to better explain its association with Aβ and tau PET staging.
-
Over 20% of patients with Alzheimer's disease (AD) worldwide are Chinese, although the efficacy of existing blood-based measures of AD biomarkers is largely unknown in Asian cohorts.
-
Plasma BD-tau is a valuable marker for CJD prognostication.
-
This paper highlights the growing evidence that blood-based tau biomarkers have early diagnostic utility for Alzheimer's disease.
-
45/100
This study shows preliminary data on the potential combined effect of amyloid-β and tau-related pathologies on the integrity of posterior brain cortices in DLB patients, whereas only amyloid-β seems to be related to MTA.